Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 13, 2025
Mursla Bio announced a collaboration with a leading global pharmaceutical company recognized for its expertise in precision medicine and biomarker-guided drug development.
read more
Thursday, November 13, 2025
Advarra and IgniteData announced a new partnership to enable research sites to securely transfer clinical data between Advarra’s eSource and electronic data capture (EDC) solutions, electronic health record (EHR) systems, and sponsor EDC systems.
read more
Monday, November 10, 2025
Avid Bioservices announced the appointment of Dave Stewart as Chief Technology and Transformation Officer, a newly created role designed to advance the company's next phase of growth and evolution.
read more
Friday, November 07, 2025
Worldwide Clinical Trials has appointed John Capicchioni as Senior Vice President, Commercial, Early Phase. In this role, Capicchioni will lead business development and commercial activities for Worldwide’s Early Phase business unit, which includes ...
read more
Thursday, November 06, 2025
Piramal Pharma announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2025.
read more
Thursday, November 06, 2025
Argonaut Manufacturing Services announced the appointment of Rick Hancock as Chief Executive Officer (CEO).
read more
Thursday, November 06, 2025
Symbiosis Pharmaceutical Services has strengthened its business development team in the US with the dual appointments of Kevin O’Brien and LeeAnn Nguyen as Vice Presidents of Business Development for North America, and North America and Asia ...
read more
Thursday, November 06, 2025
Abzena and Mabqi announced the formation of a strategic partnership that will integrate Mabqi's antibody discovery capabilities with Abzena's development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug ...
read more
Thursday, November 06, 2025
Lonza announced that it has signed an agreement to acquire Redberry SAS (Redberry), an innovative company specializing in rapid microbiology testing solutions using solid-phase cytometry (SPC) technology.
read more
Thursday, November 06, 2025
Ardena announced the appointment of Dipesh Patel as Chief Quality Officer and Peter Rose as Chief Information Officer. These appointments strengthen Ardena’s executive leadership team and reflect its continued focus on quality, compliance, and ...
read more
Wednesday, November 05, 2025
Cencora announced plans to invest $1 billion through 2030 to bolster and expand its pharmaceutical distribution network in the United States. The investments — headlined by the opening of its second national distribution center in Ohio and an ...
read more
Monday, November 03, 2025
Peli BioThermal announced that its newly expanded Allentown, Pennsylvania Service Center is officially open for business. The upgraded facility strengthens the company's Global Services Network, supporting increased customer demand, new product ...
read more
Monday, November 03, 2025
Ginkgo Bioworks has been awarded a contract through the Biomedical Advanced Research and Development Authority's (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to develop innovations that strengthen and reduce the...
read more
Monday, November 03, 2025
The winners of this year’s CPHI Pharma Awards 2025 were recently announced and celebrate outstanding achievements across pharmaceutical innovation, leadership, manufacturing, sustainability, and women in pharma.
read more
Monday, November 03, 2025
Abzena announced that Orion has obtained an exclusive focused commercial license to one of Abzena’s monoclonal antibodies (mAbs) that targets a cancer of high clinical unmet need. The antibody will strengthen Orion’s broad oncology-focused drug ...
read more